Overexpression of mitogen-activated protein kinase kinase kinase reversed cAMP inhibition of NF-kappaB in T cells
- PMID: 9022022
- DOI: 10.1002/eji.1830270133
Overexpression of mitogen-activated protein kinase kinase kinase reversed cAMP inhibition of NF-kappaB in T cells
Abstract
cAMP inhibits T cell activation by acting as an antagonist for selective kinases and transcriptional factors. We have recently demonstrated that cAMP inhibited c-Jun N-terminal kinase (JNK) but left the mitogen-activated protein (MAP) kinase cascade almost unaffected in T lymphocytes. In accordance with recent reports, we also observed a selective suppression of nuclear factor NF-kappaB activation by cAMP. The possible link between the JNK cascade and NF-kappaB activation was demonstrated by the fact that the active form of MAP kinase kinase kinase (deltaMEKK), a constitutive activator of JNK, induced NF-kappaB but not AP-1, Oct, and NF-AT in T cells. In contrast, the induction of MAP kinase kinase (MEK)-MAP kinase did not stimulate NF-kappaB activity. The specific activation of NF-kappaB by a single MEKK-JNK cascade was thus unusual, given that the activation of other transcriptional elements in T cells requires at least two signal pathways. This was further confirmed by the fact that cAMP inhibition of NF-kappaB activation was reversed by overexpression of deltaMEKK.
Similar articles
-
Lead activates nuclear transcription factor-kappaB, activator protein-1, and amino-terminal c-Jun kinase in pheochromocytoma cells.Toxicol Appl Pharmacol. 1999 Mar 15;155(3):280-6. doi: 10.1006/taap.1999.8624. Toxicol Appl Pharmacol. 1999. PMID: 10079214
-
Genetic deletion of PKR abrogates TNF-induced activation of IkappaBalpha kinase, JNK, Akt and cell proliferation but potentiates p44/p42 MAPK and p38 MAPK activation.Oncogene. 2007 Feb 22;26(8):1201-12. doi: 10.1038/sj.onc.1209906. Epub 2006 Aug 21. Oncogene. 2007. PMID: 16924232
-
Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.Oncogene. 2000 Sep 28;19(41):4685-94. doi: 10.1038/sj.onc.1203836. Oncogene. 2000. PMID: 11032018
-
Ubiquitin signalling in the NF-kappaB pathway.Nat Cell Biol. 2005 Aug;7(8):758-65. doi: 10.1038/ncb0805-758. Nat Cell Biol. 2005. PMID: 16056267 Free PMC article. Review.
-
Signal transduction induced by opioids in immune cells: a review.Neuroimmunomodulation. 2006;13(1):1-7. doi: 10.1159/000092107. Epub 2006 Apr 3. Neuroimmunomodulation. 2006. PMID: 16612131 Review.
Cited by
-
Nuclear factor of activated T cells c is a target of p38 mitogen-activated protein kinase in T cells.Mol Cell Biol. 2003 Sep;23(18):6442-54. doi: 10.1128/MCB.23.18.6442-6454.2003. Mol Cell Biol. 2003. PMID: 12944472 Free PMC article.
-
Deltex regulates T-cell activation by targeted degradation of active MEKK1.Mol Cell Biol. 2005 Feb;25(4):1367-78. doi: 10.1128/MCB.25.4.1367-1378.2005. Mol Cell Biol. 2005. PMID: 15684388 Free PMC article.
-
Inhibition of phosphodiesterase type IV suppresses human immunodeficiency virus type 1 replication and cytokine production in primary T cells: involvement of NF-kappaB and NFAT.J Virol. 1998 Jun;72(6):4712-20. doi: 10.1128/JVI.72.6.4712-4720.1998. J Virol. 1998. PMID: 9573235 Free PMC article.
-
Powering through ribosome assembly.RNA. 2009 Dec;15(12):2083-104. doi: 10.1261/rna.1792109. Epub 2009 Oct 22. RNA. 2009. PMID: 19850913 Free PMC article. Review.
-
Cyclic AMP: a selective modulator of NF-κB action.Cell Mol Life Sci. 2011 Dec;68(23):3823-41. doi: 10.1007/s00018-011-0757-8. Epub 2011 Jul 9. Cell Mol Life Sci. 2011. PMID: 21744067 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
